Cellectis (CLLS) Gross Profit Growth (1y) (2016 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 75.94% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 7.76% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 16.94% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 2,488.21% |
| 10 | Cellectis | 20.83 Bn | 20.62 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 170.71% |
| Sep 30, 2023 | -10.42% |
| Jun 30, 2023 | -87.42% |
| Mar 31, 2023 | -115.23% |
| Dec 31, 2022 | 161.41% |
| Sep 30, 2022 | 78.69% |
| Jun 30, 2022 | 269.20% |
| Mar 31, 2022 | -92.67% |
| Dec 31, 2021 | 98.60% |
| Sep 30, 2021 | 45.09% |
| Jun 30, 2021 | 80.25% |
| Mar 31, 2021 | -61.66% |
| Dec 31, 2020 | -306.43% |
| Sep 30, 2020 | -138.79% |
| Jun 30, 2020 | -968.55% |
| Mar 31, 2020 | 10,017.33% |
| Dec 31, 2019 | -595.56% |
| Sep 30, 2019 | 11,034.21% |
| Jun 30, 2019 | -92.49% |
| Mar 31, 2019 | -91.76% |
| Dec 31, 2018 | -95.89% |
| Sep 30, 2018 | -99.32% |
| Jun 30, 2018 | 2,049.21% |
| Mar 31, 2018 | -10.92% |
| Dec 31, 2017 | -20.52% |
| Sep 30, 2017 | -49.13% |
| Jun 30, 2017 | -39.58% |
| Mar 31, 2017 | -15.08% |
| Dec 31, 2016 | -78.18% |
| Sep 30, 2016 | 35.07% |
| Jun 30, 2016 | -95.49% |
| Mar 31, 2016 | -20.14% |